UB Paderborn / Katalog / Suche / in CDI

Major bleeding risks of different low‐molecular‐weight heparin agents: a cohort study in 12 934 patients treated for acute venous thrombosis

Journal of thrombosis and haemostasis, 2017-07, Vol.15 (7), p.1386-1391

2017

Link zum Volltext

Verfügbarkeit prüfen

Relationship between neighborhood socioeconomic status and venous thromboembolism: results from a population‐based study

Journal of thrombosis and haemostasis, 2017-12, Vol.15 (12), p.2352-2360

2017

Link zum Volltext

Verfügbarkeit prüfen

Suspected tuberculosis case detection and referral in private pharmacies in Viet Nam

The international journal of tuberculosis and lung disease, 2012-12, Vol.16 (12), p.1625

2012

Link zum Volltext

Verfügbarkeit prüfen

Inappropriate prescriptions of direct oral anticoagulants (DOACs) in hospitalized patients: A narrative review

Thrombosis research, 2023-11, Vol.231, p.135-140

2023

Link zum Volltext

Verfügbarkeit prüfen

Absolute Risk of Death is Lower in Left Ventricular Assist Device Patients with Good Anticoagulation Control

The Journal of heart and lung transplantation, 2021-04, Vol.40 (4), p.S387-S387

2021

Link zum Volltext

Verfügbarkeit prüfen

Increased risk of major bleeding after a minor bleed during treatment with vitamin K antagonists is determined by fixed common risk factors

Journal of thrombosis and haemostasis, 2016-05, Vol.14 (5), p.948-952

2016

Link zum Volltext

Verfügbarkeit prüfen

Impact of point‐of‐care international normalized ratio monitoring on quality of treatment with vitamin K antagonists in non‐self‐monitoring patients: a cohort study

Journal of thrombosis and haemostasis, 2016-04, Vol.14 (4), p.695-703

2016

Link zum Volltext

Verfügbarkeit prüfen

Performance of risk scores in predicting major bleeding in left ventricular assist device recipients: a comparative external validation

Research and practice in thrombosis and haemostasis, 2024-05, Vol.8 (4), p.102437, Article 102437

2024

Link zum Volltext

Verfügbarkeit prüfen

Vitamin K1 in oral solution or tablets: a crossover trial and two randomized controlled trials to compare effects

Journal of thrombosis and haemostasis, 2014-12, Vol.12 (12), p.2017-2023

2014

Link zum Volltext

Verfügbarkeit prüfen

ABCA3 mutations in adult pulmonary fibrosis patients: a case series and review of literature

Current opinion in pulmonary medicine, 2020-05, Vol.26 (3), p.293

2020

Link zum Volltext

Verfügbarkeit prüfen

Integrating healthcare for follow‐up of adult COVID‐19 patients in an outpatient clinic: A matter of cooperation

Health science reports, 2022-03, Vol.5 (2), p.e504-n/a

2022

Link zum Volltext

Verfügbarkeit prüfen

Bridging therapy and risk of major bleeding and thrombosis in continuous-flow left ventricular assist device patients: a quasi-experimental study

European heart journal, 2023-11, Vol.44 (Supplement_2)

2023

Link zum Volltext

Verfügbarkeit prüfen

Relative risk of thrombo-embolisms and major bleedings is high in left ventricular assist device patients with unstable anticoagulation control

Atherosclerosis, 2021-08, Vol.331, p.e227-e227

2021

Link zum Volltext

Verfügbarkeit prüfen

Antithrombotic therapy and bleeding complications in patients with atrial fibrillation and active cancer

European heart journal, 2021-10, Vol.42 (Supplement_1)

2021

Link zum Volltext

Verfügbarkeit prüfen

Atrial fibrillation in patients with a history of cancer and risk of bleeding complications associated with antithrombotic therapy

European heart journal, 2021-10, Vol.42 (Supplement_1)

2021

Link zum Volltext

Verfügbarkeit prüfen

PB0012 Anticoagulant use and Prognosis of Non-Valvular Atrial Fibrillation Patients According to Baseline CHA2DS2-VASc Score and HAS-BLED Score

Research and practice in thrombosis and haemostasis, 2023-10, Vol.7, p.100699, Article 100699

2023

Link zum Volltext

Verfügbarkeit prüfen

PB0465 Trends in Anticoagulant Treatment Duration and Outcomes after Pulmonary Embolism between 2014 and 2019: A Nationwide Cohort Study

Research and practice in thrombosis and haemostasis, 2023-10, Vol.7, p.101920, Article 101920

2023

Link zum Volltext

Verfügbarkeit prüfen

Low major bleeding, pump thrombosis and death rates in continuous flow left ventricular assist devices patients with good anticoagulation control

European heart journal, 2022-10, Vol.43 (Supplement_2)

2022

Link zum Volltext

Verfügbarkeit prüfen

PB0120 Plasma Profiling of Patients on Vitamin K Antagonists Treatment: A Targeted Quantitative Proteomic Approach

Research and practice in thrombosis and haemostasis, 2023-10, Vol.7, p.100927, Article 100927

2023

Link zum Volltext

Verfügbarkeit prüfen

OC 74.3 Anticoagulant Use and Prognosis in Patients with Atrial Fibrillation and Cancer: A Nationwide Population-Based Study

Research and practice in thrombosis and haemostasis, 2023-10, Vol.7, p.100302, Article 100302

2023

Link zum Volltext

Verfügbarkeit prüfen

PB0029 Bridging Therapy and Risk of Major Bleeding and Thrombosis with Continuous-Flow Left Ventricular Assist Device: A Quasi-Experimental Study

Research and practice in thrombosis and haemostasis, 2023-10, Vol.7, p.100707, Article 100707

2023

Link zum Volltext

Verfügbarkeit prüfen

P2906Evaluation of appropriate use and clinical outcomes of idarucizumab as antidote of dabigatran in daily clinical practice

European heart journal, 2018-08, Vol.39 (suppl_1)

2018

Link zum Volltext

Verfügbarkeit prüfen

Validity of the Patient Experiences and Satisfaction with Medications (PESaM) Questionnaire

The patient : patient-centered outcomes research, 2019-02, Vol.12 (1), p.149-162

2019

Link zum Volltext

Verfügbarkeit prüfen

Towards a synthetic cell cycle

Nature communications, 2021-07, Vol.12 (1), p.4531-4531, Article 4531

2021

Link zum Volltext

Verfügbarkeit prüfen

Clinical usefulness of drug-laboratory test interaction alerts: a multicentre survey

Clinical chemistry and laboratory medicine, 2021-06, Vol.59 (7), p.1239

2021

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

Major bleeding risks of different low‐molecular‐weight heparin agents: a cohort study in 12 934 patients treated for acute venous thrombosis

Relationship between neighborhood socioeconomic status and venous thromboembolism: results from a population‐based study

Suspected tuberculosis case detection and referral in private pharmacies in Viet Nam

Inappropriate prescriptions of direct oral anticoagulants (DOACs) in hospitalized patients: A narrative review

Absolute Risk of Death is Lower in Left Ventricular Assist Device Patients with Good Anticoagulation Control

Increased risk of major bleeding after a minor bleed during treatment with vitamin K antagonists is determined by fixed common risk factors

Impact of point‐of‐care international normalized ratio monitoring on quality of treatment with vitamin K antagonists in non‐self‐monitoring patients: a cohort study

Performance of risk scores in predicting major bleeding in left ventricular assist device recipients: a comparative external validation

Vitamin K1 in oral solution or tablets: a crossover trial and two randomized controlled trials to compare effects

ABCA3 mutations in adult pulmonary fibrosis patients: a case series and review of literature

Integrating healthcare for follow‐up of adult COVID‐19 patients in an outpatient clinic: A matter of cooperation

Bridging therapy and risk of major bleeding and thrombosis in continuous-flow left ventricular assist device patients: a quasi-experimental study

Relative risk of thrombo-embolisms and major bleedings is high in left ventricular assist device patients with unstable anticoagulation control

Antithrombotic therapy and bleeding complications in patients with atrial fibrillation and active cancer

Atrial fibrillation in patients with a history of cancer and risk of bleeding complications associated with antithrombotic therapy

PB0012 Anticoagulant use and Prognosis of Non-Valvular Atrial Fibrillation Patients According to Baseline CHA2DS2-VASc Score and HAS-BLED Score

PB0465 Trends in Anticoagulant Treatment Duration and Outcomes after Pulmonary Embolism between 2014 and 2019: A Nationwide Cohort Study

Low major bleeding, pump thrombosis and death rates in continuous flow left ventricular assist devices patients with good anticoagulation control

PB0120 Plasma Profiling of Patients on Vitamin K Antagonists Treatment: A Targeted Quantitative Proteomic Approach

OC 74.3 Anticoagulant Use and Prognosis in Patients with Atrial Fibrillation and Cancer: A Nationwide Population-Based Study

PB0029 Bridging Therapy and Risk of Major Bleeding and Thrombosis with Continuous-Flow Left Ventricular Assist Device: A Quasi-Experimental Study

P2906Evaluation of appropriate use and clinical outcomes of idarucizumab as antidote of dabigatran in daily clinical practice

Validity of the Patient Experiences and Satisfaction with Medications (PESaM) Questionnaire

Towards a synthetic cell cycle

Clinical usefulness of drug-laboratory test interaction alerts: a multicentre survey

Suchergebnisse filtern